Physician Do No Harm

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2011; 55: 245–264.

Gane E.J. , Stedman C.A. , Hyland R.H. ELECTRON: once daily PSI-7977 plus RBV in HCV GT1/2/3. J Hepatol 2012; 56 Suppl 2: S438–S439.

Poordad F. , Lawitz E. , Kowdley K.V. 12-week interferon-free regimen of ABT-450/r + ABT-333 + ribavirin achieved SVR₁₂ in more than 90% of treatment-naive HCV genotype-1-infected subjects and 47% of previous non-responders. J Hepatol 2012; 56 Suppl 2: S549–S550.

Zeuzem S. , Andreone P. , Pol S. Telaprevir for retreatment of HCV infection. N Engl J Med 2011; 364: 2417–2428.